From: ITPKA expression is a novel prognostic factor in hepatocellular carcinoma
Clinical features | OS | RFS | ||
---|---|---|---|---|
HR (95 % CI) | P value | HR (95 % CI) | P value | |
Age | 0.678 (0.420–1.096) | 0.113 | 0.653 (0.409–1.041) | 0.073 |
Gender | 2.297 (0.562–9.390) | 0.247 | 2.526 (0.619–10.316) | 0.197 |
HBsAg | 3.379 (1.061–10.763) | 0.039 | 3.581 (1.126–11.394) | 0.031 |
AFP | 2.187 (1.246–3.839) | 0.006 | 2.000 (1.171–3.418) | 0.011 |
Cirrhosis | 1.025 (0.549–1.916) | 0.937 | 1.127 (0.605–2.097) | 0.707 |
Tumor size | 2.161 (1.279–3.653) | 0.004 | 1.870 (1.135–3.081) | 0.014 |
Tumor number | 2.475 (1.488–4.118) | <0.001 | 2.576 (1.574–4.216) | <0.001 |
Tumor encapsulation | 0.674 (0.392–1.161) | 0.155 | 0.722 (0.429–1.215) | 0.221 |
Vascular invasion | 6.074 (3.449–10.698) | <0.001 | 5.722 (3.236–10.119) | <0.001 |
Edmondson-Steiner | 1.348 (0.832–2.186) | 0.225 | 1.296 (0.810–2.074) | 0.279 |
TNM stage | 4.919 (3.014–8.082) | <0.001 | 4.282 (2.654–6.907) | <0.001 |
ITPKA expression | 2.579 (1.567–4.245) | <0.001 | 2.669 (1.638–4.349) | <0.001 |